Objective: As the number of recovering COVID-19 patients increases worldwide, the persistence of symptoms and signs through the post-acute phase indicates an urgent need for prolonged follow-up care. To explore existing data about post-acute COVID-19 syndrome, this meta-analysis assesses the...
Abstract
Porphyromonas gingivalis (P. gingivalis), a key pathogen in periodontitis, has been shown to accelerate the progression of atherosclerosis (AS). However, the definite mechanisms remain elusive. Emerging evidence supports an association between mitochondrial dysfunction and AS.
In our...
Abstract
Background
Dyspnea and exercise intolerance are commonly reported post-acute sequelae of SARS-CoV-2 infection (PASC), but routine diagnostic testing is often normal. Cardiopulmonary exercise testing (CPET) offers comprehensive assessment of dyspnea to characterize pulmonary PASC...
Highlights
• ME/CFS, a clinical entity of unknown etiology characterized by PEM, is easily diagnosed when following available guidelines.
• Patients with ME/CFS typically have small hearts, low stroke volume, and low total blood volume, and some have OI.
• More studies are needed to understand...
Abstract
Objectives: This study aimed to explore the experience of cognitive behavioural therapy (CBT) aimed at better management of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME), rather than increasing activity.
Design: This was a qualitative study using grounded theory...
Abstract
Background
The tryptophan–kynurenine–nicotinamide adenine dinucleotide (oxidized; NAD+) pathway is closely associated with regulation of immune cells toward less inflammatory phenotypes and may exert neuroprotective effects. Investigating its regulation in central nervous system (CNS)...
frontiers in Systems Neuroscience
Acute Corticotropin-Releasing Factor Receptor Type 2 Agonism Result in Sustained Improvement in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome by Pereira, Bateman et al
Background: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex...
Predictors of Nonseroconversion after SARS-CoV-2 Infection
https://wwwnc.cdc.gov/eid/article/27/9/21-1042_article
____________________
CDC study finds that 36% of COVID patients never make antibodies
This has implications for prevalence studies of long covid that assume a lack of...
Abstract
Functional autoantibodies directed to the M2 muscarinic acetylcholine receptor (M2R) could affect the heart rate directly by altering cardiac M2R activity and/or indirectly by changing vagal-mediated cardiac M2R activity. We measured M2R autoantibody activity in sera from 10 subjects...
Abstract
Long-COVID-19 is a proposed syndrome negatively affecting the health of COVID-19 patients. We present data on self-rated health three to eight months after laboratory confirmed COVID-19 disease compared to a control group of SARS-CoV-2 negative patients.
We followed a cohort of 8786...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1371754/
Abstract
In order to examine the prevalence of patients with symptoms fulfilling the criteria for the chronic fatigue syndrome an extensive survey was carried out of general practitioners on 10 local government lists in two health boards...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1371214/
Abstract
A case definition for post-viral fatigue syndrome is proposed within which various subgroups of patients exist. Any one treatment may not apply to all the subgroups. In particular, patients' experiences do not show that avoidance of...
Highlights
• Long Covid is a patient-defined illness which gained legitimacy in online communities.
• We analysed long Covid narratives using socio-narratology.
• Narrators used literary devices to make sense of illness and persuade their audiences.
• A unique feature of many narratives was...
Abstract
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating disease usually presenting after infection. Emerging evidence supports that energy metabolism is affected in ME/CFS, but a unifying metabolic phenotype has not been firmly established.
We performed global...
Not new but thought it might be of interest.
(the Peer Review report is also available , one of the reviewers is Chew-Graham)
Abstract
Background
Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) can cause profound and prolonged illness and disability, and poses significant problems...
Highlights
• CBT is a promising treatment for patients with FND.
• Remote delivery of CBT can potentially increase access to care for patients with FND.
• Remote CBT can be integrated into clinical practice using a stepwise approach.
• Remote CBT can be integrated into practice using...
BACKGROUND
Fibromyalgia (FM) and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) are devastating metabolic neuroimmune diseases that are difficult to diagnose because of the presence of numerous symptoms and a lack of specific biomarkers. Despite patient heterogeneity linked to...
Autoantibodies to Vasoregulative G-Protein-Coupled Receptors Correlate with Symptom Severity, Autonomic Dysfunction and Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Scheibenbogen et al
Abstract
Background: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is an...
Abstract
PRINCE Secondary was a randomised trial to test the efficacy and cost-effectiveness of therapist-delivered, transdiagnostic cognitive behavioural therapy (TDT-CBT) for patients with persistent physical symptoms (PPS) (Chalder et al., 2021). In total, 324 PPS patients were randomised to...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.